ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+27.06%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$477M
AUM Growth
+$477M
(+18%)
Cap. Flow
+$20.7M
Cap. Flow
% of AUM
4.34%
Top 10 Holdings %
Top 10 Hldgs %
81.11%
Holding
86
New
9
Increased
11
Reduced
4
Closed
11
Top Buys
| 1 |
Gyre Therapeutics
GYRE
|
$18.2M |
| 2 |
Arrowhead Research
ARWR
|
$12.7M |
| 3 |
Tandem Diabetes Care
TNDM
|
$6.68M |
| 4 |
Rocket Pharmaceuticals
RCKT
|
$6.56M |
| 5 |
argenx
ARGX
|
$6.5M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$13.1M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$12M |
| 3 |
PDS Biotechnology
PDSB
|
$8.84M |
| 4 |
Evolent Health
EVH
|
$5.17M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$4.42M |
Sector Composition
| 1 | Healthcare | 78.81% |
| 2 | Communication Services | 0% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $85.5M | 13.96% | 5,850,000 -900,000 | -13% | -$13.1M |
|
2
Iovance Biotherapeutics
IOVA
$807M
| $72M | 11.76% | 4,260,000 +368,000 | +9% | +$6.22M |
|
3
Assembly Biosciences
ASMB
$190M
| $54.8M | 8.95% | 1,115,000 +27,896 | +3% | +$1.37M |
|
4
Ascendis Pharma
ASND
$11.8B
| $35.6M | 5.81% | 544,000 +13,000 | +2% | +$850K |
|
|
5
argenx
ARGX
$43.6B
| $32.5M | 5.31% | 403,821 +80,821 | +25% | +$6.5M |
|
|
6
Gyre Therapeutics
GYRE
$703M
| $29.8M | 4.87% | 1,154,722 +704,722 | +157% | +$18.2M |
|
|
KDMN
7
DELISTED
Kadmon Holdings, Inc.
KDMN
| $25.3M | 4.13% | 5,950,000 +1,035,000 | +21% | +$4.4M |
|
8
Veracyte
VCYT
$2.39B
| $18.4M | 3.01% | 3,318,000 +22,889 | +0.7% | +$127K |
|
9
Indaptus Therapeutics
INDP
$7.19M
| $17.2M | 2.81% | 2,724,283 | – | – |
|
|
CEMI
10
DELISTED
Chembio diagnostics, Inc.
CEMI
| $16.1M | 2.62% | 2,006,667 +285,368 | +17% | +$2.28M |
|
|
11
Arrowhead Research
ARWR
$3.05B
| $12.7M | 2.08% | +1,762,206 | New | +$12.7M |
|
|
VRAY
12
DELISTED
ViewRay, Inc.
VRAY
| $11.9M | 1.95% | 1,852,878 -62,776 | -3% | -$404K |
|
13
IRIDEX
IRIX
$22.8M
| $11.4M | 1.87% | 2,000,000 | – | – |
|
|
AVXS
14
DELISTED
AveXis, Inc. Common Stock
AVXS
| $7.42M | 1.21% | 60,000 +7,100 | +13% | +$877K |
|
|
15
Tandem Diabetes Care
TNDM
$845M
| $6.68M | 1.09% | +1,346,360 | New | +$6.68M |
|
|
CASM
16
DELISTED
CAS Medical Systems, Inc.
CASM
| $6.57M | 1.07% | 5,216,998 +56,998 | +1% | +$71.8K |
|
|
17
Rocket Pharmaceuticals
RCKT
$354M
| $6.56M | 1.07% | +350,000 | New | +$6.56M |
|
|
CUTR
18
DELISTED
Cutera, Inc.
CUTR
| $3.52M | 0.57% | +70,000 | New | +$3.52M |
|
|
MRTX
19
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.07M | 0.5% | 100,000 -55,000 | -35% | -$1.69M |
|
20
Fennec Pharmaceuticals
FENC
$247M
| $3.02M | 0.49% | 250,000 | – | – |
|
|
ARMO
21
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
| $2.99M | 0.49% | +80,000 | New | +$2.99M |
|
|
NBRV
22
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $2.82M | 0.46% | 559,739 -20,261 | -3% | -$102K |
|
|
VIVE
23
DELISTED
VIVEVE MED INC
VIVE
| $2.51M | 0.41% | 685,215 +251,796 | +58% | +$922K |
|
24
Q32 Bio
QTTB
$20.9M
| $1.48M | 0.24% | +79,000 | New | +$1.48M |
|
|
RARX
25
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $1.43M | 0.23% | +270,000 | New | +$1.43M |
|